Merck to unveil its latest Milli-Q® Ultrapure Water System during Live Virtual Launch on 22nd Nov for its Indian customers
Expands its Ultrapure Water Portfolio with the Milli-Q® EQ 7008/16 Water Purification System
Merck has expanded its benchtop water system portfolio, with the launch of its new Milli-Q® EQ 7008/16 ultrapure and pure water purification system. The India Live launch is scheduled on Tuesday, 22nd November 2022 at 11 am SGT. To join the launch, register here.
With this launch, Merck has once again demonstrated its commitment to meeting the purified water needs of every scientist, while remaining at the forefront of innovation in lab water purification.
The new Milli-Q® EQ 7008/16 system produces consistent ultrapure (Type 1) water quality direct from a tap water source and includes an option to obtain reverse osmosis (RO, Type 3) quality water. Final ultrapure water quality can be easily adapted to experimental requirements through a selection of final filters. Dedicated innovations make the system convenient and effortless to use, while monitoring technologies provide confidence that every dispense is of high quality.
This new system strengthens Merck’s Milli-Q® ultrapure water offering that includes Milli-Q® IQ 7003/05/10/15 ultrapure and pure water systems, the Milli-Q® IQ 7000 ultrapure water system, and the Milli-Q® EQ 7000 ultrapure water system. The Milli-Q® IQ series of systems differs from the Milli-Q® EQ series in that the former offers a full qualification program, advanced data traceability, highly accurate A10® TOC monitoring and has been awarded Merck’s Greener Alternative Product label.
To know more about this latest innovation, register for its India LIVE Virtual Launch Event on Tuesday, 22nd Nov 2022. Click here to register to attend the launch.
For more information, contact:
Vinita Singh | Senior Product Manager – South APAC, Lab Water Solutions, Merck
About Merck
Merck, a leading science and technology company, operates across healthcare, life science and electronics. Around 60,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2021, Merck generated sales of € 19.7 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics.
